Skip to content
healthcare.dev

Rasagiline

NDC 80005-141, Rasagiline mesylate, tablet, from Carnegie Pharmaceuticals LLC.

Product NDC
80005-141
Status
Listed
Labeler
Carnegie Pharmaceuticals LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201942
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/80005-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE.5 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
80005-141-088000501410830 TABLET in 1 BOTTLE (80005-141-08)
80005-141-108000501411090 TABLET in 1 BOTTLE (80005-141-10)
80005-141-1480005014114500 TABLET in 1 BOTTLE (80005-141-14)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e84da5ee-f93a-4e0e-9120-7dfcb9d18430

Use it

Look up 80005-141 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/80005-141 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 80005-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.